TSC
Showing 1 - 25 of 236
AML, MDS, ALL, Adult Trial in Hackensack, New York (SOC + TSC-100, SOC + TSC-101, Control)
Recruiting
- AML
- +2 more
- SOC + TSC-100
- +2 more
-
Hackensack, New Jersey
- +1 more
Aug 11, 2022
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)
Recruiting
- TSC
- Behavioral Symptoms
- Behavioral Intervention in a small group platform
-
Carrboro, North Carolina
- +1 more
Oct 23, 2023
Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)
Recruiting
- Tuberous Sclerosis Complex
- Epilepsy
- Sirolimus
- Placebo
-
Birmingham, Alabama
- +7 more
Sep 2, 2022
Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)
Recruiting
- Tuberous Sclerosis
- Lymphangioleiomyomatosis
- Phlebotomy
- +3 more
-
Birmingham, Alabama
- +22 more
Jan 6, 2023
TSC Trial in Los Angeles (JASPER)
Recruiting
- TSC
- JASPER
-
Los Angeles, CaliforniaUCLA Semel Institute
Feb 1, 2022
Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))
Active, not recruiting
- Tuberous Sclerosis Complex
- Epilepsy
- TAVT-18 (sirolimus)
-
Cincinnati, OhioCincinnati Children's Hospital
Jan 10, 2022
Tuberous Sclerosis Complex Trial in United States (Ganaxolone)
Enrolling by invitation
- Tuberous Sclerosis Complex
-
Phoenix, Arizona
- +13 more
Jan 24, 2023
SARS-CoV-2 (Covid19) Trial in Bucharest (Trans Sodium Crocetinate, Normal saline)
Completed
- SARS-CoV-2 (Covid19)
- Trans Sodium Crocetinate
- Normal saline
-
Bucharest, RomaniaNational Institute of Infectious Diseases- Prof. Dr. Matei Balş
Apr 12, 2022
Tuberous Sclerosis Trial in United States (GNX oral suspension, TID, Placebo)
Recruiting
- Tuberous Sclerosis
- GNX oral suspension, TID
- Placebo
-
Phoenix, Arizona
- +36 more
Oct 28, 2022
Lymphangioleiomyomatosis (LAM) Trial in Boston (Celecoxib)
Completed
- Lymphangioleiomyomatosis (LAM)
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 18, 2022
Tuberous Sclerosis Complex Trial in Lodz, Warsaw (Rapamycin, Placebo)
Not yet recruiting
- Tuberous Sclerosis Complex
- Rapamycin
- Placebo
-
Lodz, Poland
- +1 more
Sep 6, 2022
Healthy Subjects Trial in Overland Park (Trans-Sodium Crocetinate, Placebo)
Completed
- Healthy Subjects
- Trans-Sodium Crocetinate
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas Inc
Aug 20, 2021
Stroke, Acute Trial in Los Angeles, Charlottesville (Trans-Sodium Crocetinate, Placebo)
Terminated
- Stroke, Acute
- Trans-Sodium Crocetinate
- Placebo
-
Los Angeles, California
- +1 more
May 24, 2021
Malignant Solid Tumors Trial (Sirolimus for Injection (Albumin-bound))
Not yet recruiting
- Malignant Solid Tumors
- Sirolimus for Injection (Albumin-bound)
- (no location specified)
Aug 19, 2022
HIV/AIDS, Trauma Trial in Boston, Toronto (CBT-TSC, Life Steps and Sexual Decision-Making)
Completed
- HIV/AIDS
- Trauma
- CBT-TSC
- Life Steps and Sexual Decision-Making
-
Boston, Massachusetts
- +1 more
Apr 7, 2023
Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)
Completed
- Epilepsy
- +2 more
-
New York, New YorkNew York University Langone Medical Center
Aug 31, 2021
Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)
Recruiting
- Tuberous Sclerosis Complex
- NPC-12Y gel
- NPC-12Y placebo gel
-
Toyoake, Aichi, Japan
- +4 more
Aug 8, 2022
Autism Spectrum Disorder and Intellectual Disability
Recruiting
- Tuberous Sclerosis
- +2 more
-
Birmingham, Alabama
- +5 more
Jul 29, 2021
Tuberous Sclerosis Complex, Self-injury, Autism Trial in Baltimore (Sirolimus, Everolimus)
Completed
- Tuberous Sclerosis Complex
- +2 more
-
Baltimore, MarylandKennedy Krieger Institute
Mar 26, 2021
Autism in Infants With Tuberous Sclerosis Complex (TSC)
Completed
- Tuberous Sclerosis Complex
-
Birmingham, Alabama
- +4 more
Feb 2, 2021